258 related articles for article (PubMed ID: 23820042)
1. Tocilizumab in refractory Takayasu arteritis: a case series and updated literature review.
Abisror N; Mekinian A; Lavigne C; Vandenhende MA; Soussan M; Fain O;
Autoimmun Rev; 2013 Oct; 12(12):1143-9. PubMed ID: 23820042
[TBL] [Abstract][Full Text] [Related]
2. Rapid control of disease activity by tocilizumab in 10 'difficult-to-treat' cases of Takayasu arteritis.
Goel R; Danda D; Kumar S; Joseph G
Int J Rheum Dis; 2013 Dec; 16(6):754-61. PubMed ID: 24382284
[TBL] [Abstract][Full Text] [Related]
3. Tocilizumab and refractory Takayasu disease: Four case reports and systematic review.
Decker P; Olivier P; Risse J; Zuily S; Wahl D
Autoimmun Rev; 2018 Apr; 17(4):353-360. PubMed ID: 29427826
[TBL] [Abstract][Full Text] [Related]
4. Tocilizumab treatment in childhood Takayasu arteritis: Case series of four patients and systematic review of the literature.
Batu ED; Sönmez HE; Hazırolan T; Özaltın F; Bilginer Y; Özen S
Semin Arthritis Rheum; 2017 Feb; 46(4):529-535. PubMed ID: 27515155
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of 251 patients with Takayasu arteritis on combination immunosuppressant therapy: Single centre experience from a large tertiary care teaching hospital in Southern India.
Goel R; Danda D; Joseph G; Ravindran R; Kumar S; Jayaseelan V; Jayaseelan L; Bacon P
Semin Arthritis Rheum; 2018 Apr; 47(5):718-726. PubMed ID: 29096935
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of tocilizumab in Takayasu arteritis: Multicenter retrospective study of 46 patients.
Mekinian A; Resche-Rigon M; Comarmond C; Soriano A; Constans J; Alric L; Jego P; Busato F; Cabon M; Dhote R; Estibaliz L; Koné-Paut I; Landron C; Lavigne C; Lioger B; Michaud M; Ruivard M; Sacre K; Gottenberg JE; Gaches F; Goulenok T; Salvarani C; Cacoub P; Fain O; Saadoun D;
J Autoimmun; 2018 Jul; 91():55-60. PubMed ID: 29678346
[TBL] [Abstract][Full Text] [Related]
7. Tocilizumab for Treating Takayasu's Arteritis and Associated Stroke: A Case Series and Updated Review of the Literature.
Osman M; Emery D; Yacyshyn E
J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1291-8. PubMed ID: 25869777
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of anti-interleukin 6 receptor monoclonal antibody (tocilizumab) in Colombian patients with Takayasu arteritis.
Cañas CA; Cañas F; Izquierdo JH; Echeverri AF; Mejía M; Bonilla-Abadía F; Tobón GJ
J Clin Rheumatol; 2014 Apr; 20(3):125-9. PubMed ID: 24662551
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Biological-Targeted Treatments in Takayasu Arteritis: Multicenter, Retrospective Study of 49 Patients.
Mekinian A; Comarmond C; Resche-Rigon M; Mirault T; Kahn JE; Lambert M; Sibilia J; Néel A; Cohen P; Hie M; Berthier S; Marie I; Lavigne C; Anne Vandenhende M; Muller G; Amoura Z; Devilliers H; Abad S; Hamidou M; Guillevin L; Dhote R; Godeau B; Messas E; Cacoub P; Fain O; Saadoun D;
Circulation; 2015 Nov; 132(18):1693-700. PubMed ID: 26354797
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Takayasu arteritis with the IL-6R antibody tocilizumab vs. cyclophosphamide.
Kong X; Zhang X; Lv P; Cui X; Ma L; Chen H; Liu H; Lin J; Jiang L
Int J Cardiol; 2018 Sep; 266():222-228. PubMed ID: 29729868
[TBL] [Abstract][Full Text] [Related]
11. Subcutaneous administration of tocilizumab is effective in myointimal hyperplasia remodelling in refractory Takayasu arteritis.
Lo Gullo A; Mandraffino G; Aragona CO; Molica Colella A; Saitta A; Imbalzano E
Reumatismo; 2017 Dec; 69(4):184-188. PubMed ID: 29320845
[TBL] [Abstract][Full Text] [Related]
12. Sustained remission after long-term biological therapy in patients with large vessel vasculitis: an analysis of ten cases.
Vinicki JP; García-Vicuña R; Arredondo M; López-Bote JP; García-Vadillo JA; Castañeda S; Álvaro-Gracia JM
Reumatol Clin; 2017; 13(4):210-213. PubMed ID: 27499427
[TBL] [Abstract][Full Text] [Related]
13. Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature.
Kötter I; Henes JC; Wagner AD; Loock J; Gross WL
Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S114-29. PubMed ID: 22640655
[TBL] [Abstract][Full Text] [Related]
14. Tocilizumab in treatment-naïve patients with Takayasu arteritis: TOCITAKA French prospective multicenter open-labeled trial.
Mekinian A; Saadoun D; Vicaut E; Thietart S; Lioger B; Jego P; Bleibtreu A; Limal N; Connault J; Gottenberg JE; Lhorte P; Bertola JP; Delforge J; Ferreira-Maldent N; Perlat A; Talib Z; Vautier M; Savey L; Quiere I; Cacoub P; Fain O;
Arthritis Res Ther; 2020 Sep; 22(1):218. PubMed ID: 32943098
[TBL] [Abstract][Full Text] [Related]
15. [Tocilizumab for refractory Takayasu arteritis with aortic aneurysm].
Frikha F; Garbaa S; Bouattour Y; Snoussi M; Loukil H; Ben Salah R; Bahloul Z
J Med Vasc; 2019 May; 44(3):237-239. PubMed ID: 31029281
[TBL] [Abstract][Full Text] [Related]
16. Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
Unizony S; Arias-Urdaneta L; Miloslavsky E; Arvikar S; Khosroshahi A; Keroack B; Stone JR; Stone JH
Arthritis Care Res (Hoboken); 2012 Nov; 64(11):1720-9. PubMed ID: 22674883
[TBL] [Abstract][Full Text] [Related]
17. Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study.
Nakaoka Y; Isobe M; Tanaka Y; Ishii T; Ooka S; Niiro H; Tamura N; Banno S; Yoshifuji H; Sakata Y; Kawakami A; Atsumi T; Furuta S; Kohsaka H; Suzuki K; Hara R; Maejima Y; Tsukamoto H; Takasaki Y; Yamashita K; Okada N; Yamakido S; Takei S; Yokota S; Nishimoto N
Rheumatology (Oxford); 2020 Sep; 59(9):2427-2434. PubMed ID: 31951279
[TBL] [Abstract][Full Text] [Related]
18. Tocilizumab in patients with Takayasu arteritis: a retrospective study and literature review.
Loricera J; Blanco R; Hernández JL; Castañeda S; Humbría A; Ortego N; Bravo B; Freire M; Melchor S; Mínguez M; Salvatierra J; González-Vela C; Calvo-Río V; Santos-Gómez M; Pina T; González-Gay MA
Clin Exp Rheumatol; 2016; 34(3 Suppl 97):S44-53. PubMed ID: 27050507
[TBL] [Abstract][Full Text] [Related]
19. Regressed coronary ostial stenosis in a young female with Takayasu arteritis: a case report.
Yokokawa T; Kunii H; Kaneshiro T; Ichimura S; Yoshihisa A; Yashiro Furuya M; Asano T; Nakazato K; Ishida T; Migita K; Takeishi Y
BMC Cardiovasc Disord; 2019 Apr; 19(1):79. PubMed ID: 30940076
[TBL] [Abstract][Full Text] [Related]
20. Treatment of refractory Takayasu arteritis with tocilizumab: 7 Italian patients from a single referral center.
Tombetti E; Franchini S; Papa M; Sabbadini MG; Baldissera E
J Rheumatol; 2013 Dec; 40(12):2047-51. PubMed ID: 24187104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]